• Cancel
    Date：2024-05
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=775

    Recently, Blue Sail Medical (002382.SZ) announced that its cardiovascular and cerebrovascular business unit, Blue Sail Biosensors, has raised a total of RMB 1 billion in funding. The Series A2 round introduced an additional RMB 100 million, following a RM

  • Cancel
    Date：2024-05

    Exclusive Financial Advisor to MagAssist

  • Cancel
    Date：2024-05
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=773

    Recently, Vision Medicals announced a successful completion of D+ round funding worth hundreds of millions RMB, with Kequan Fund as lead-investor and Tianxin Fund as co-investor. Funds raised in this round will be primarily used to promote the research an

  • Cancel
    Date：2024-03

    Exclusive Financial Advisor to HYGIEIA

  • Cancel
    Date：2024-03
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=772

    Recently, InfiMotion announced the completion of hundreds of millions of yuan in Series A funding. The round was led by the National Adjustment Fund, with participation from Wuxi New Energy Industry Fund, Huiheng Industry, Huishan Financial Services, and

  • Cancel
    Date：2024-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=771

    On February 21, 2024, Yantai Dongcheng Biochemicals (002675) announced that its wholly-owned subsidiary, Yitai Pharmaceutical, intends to purchase the 99mTc-GSA injection and GSA cold kit (hereinafter referred to as the "target product") held by Rongcheng

  • Cancel
    Date：2024-02
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=770

    Today, Affection Animal Pharmaceuticals successfully completed a Series C funding round worth hundreds of millions of yuan. This equity financing was co-led by Yuanxi Haihe Fund and Songqing Shenhui Jiarui Private Investment Fund, with Guohai Innovation C

  • Cancel
    Date：2024-01
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=768

    On January 8, 2024, Rokid officially signed the "Lingban Smart Investment Cooperation Agreement" with the Hefei Municipal Government. The two parties will collaborate on the development of the metaverse industry and engage in deep cooperation. Simultaneou

  • Cancel
    Date：2023-11
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=767

    This innovative platform specializes in recombinant protein drugs for metabolic diseases. QL Biopharm announces the completion of a nearly 200 million B+ round of financing. IMEIK and China US Green Fund led this financing round, with significant contrib